Business
Cryoport Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters to Purchase Additional Shares
NASHVILLE, Tenn., Jan. 25, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply
About this update from Cryoport, Inc.
[{"type":"text","content":" NASHVILLE, Tenn., Jan. 25, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) (\"Cryoport\" or the \"Company\"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the closing of an underwritten public offering of 4,356,059 shares of its common stock, at a public offering price of $66.00 per share, which includes 568,181 shares issued following the full exercise by the underwriters of their option to purchase additional shares at the public offering price, before deducting underwriting discounts and commissions. \n\n \n \n \n \n \n \n\n \nThe gross proceeds from the offering to Cryoport, before deducting the underwriting discounts and commissions and other offering expenses, were approximately $287.5 million. The Company expects to use the net proceeds from the offering of the shares for general corporate purposes, which may include working capital, inventory development, global infrastructure buildout and facilities expansion, sales and marketing.\nMorgan Stanley, Jefferies, SVB Leerink, and UBS Investment Bank acted as joint book-running managers for the offering.\nThe public offering was made pursuant to an automatic shelf registration statement on Form S-3 that was previously filed with the Securities and Exchange Commission (the \"SEC\") and automatically became effective upon filing. A final prospectus supplement and accompanying prospectus relating to and describing the final terms of the offering have been filed with the SEC and are available on the SEC's website located at http://www.sec.gov or may be obtained from Morgan Stanley, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014; Jefferies, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at (877) 821-7388 or by email at [email protected]; SVB Leerink, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, or by telephone at (800) 808-7525, ext. 6132 or by email at [email protected]; or UBS Securities LLC, Attention: Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019, by telephone at (888) 827-7275 or by email at [email protected].\nThis press release shall not constitute an offer to sell or the solicitation of an off...